Literature DB >> 10460208

Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet.

H Yokogoshi1, H Mochizuki, K Nanami, Y Hida, F Miyachi, H Oda.   

Abstract

The effect of taurine on hypercholesterolemia induced by feeding a high-cholesterol (HC) diet (10g/kg) to rats was examined. When various amounts of taurine (0.25, 0.5, 1, 2.5, 5, 10, 20, 30, 40 or 50 g/kg diet) were supplemented to HC for 2 wk, serum total cholesterol gradually and significantly decreased in a dose-dependent manner and normalized at the dose of 10 g taurine/kg, compared with the control (cholesterol free) diet group. By contrast, serum HDL-cholesterol was elevated by taurine supplementation. The HC diet caused a significant decrease in the concentration of taurine in serum, liver and heart compared to that in the control group, and the effective dose of supplemental taurine to improve its reduction was 2.5 g/kg diet. In the hypercholesterolemic rats fed the HC diet, the excretion of fecal bile acids and hepatic cholesterol 7 alpha-hydroxylase (CYP7A1) activity and its mRNA level increased significantly, and the supplementation of taurine further enhanced these indexes, indicating an increase in cholesterol degradation. The abundance of mRNA for Apo A-I, one of the main components of HDL, was reduced by HC and recovered by taurine supplementation. Agarose gel electrophoresis revealed that, in hypercholesterolemic rats fed the HC diet, the serum level of the heavier VLDL increased significantly, but taurine repressed this increase and normalized this pattern. Significant correlations were observed between the time- and dose-dependent increases of CYP7A1 gene expression and the decrease of blood cholesterol concentration in rats fed the HC diet supplemented with taurine (time, r = -0.538, P < 0.01, n = 32; dose, r = -0.738, P < 0.001, n = 20). These results suggest that the hypocholesterolemic effects of taurine observed in the hypocholesterolemic rats fed the HC diet were mainly due to the enhancement of cholesterol degradation and the excretion of bile acid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460208     DOI: 10.1093/jn/129.9.1705

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  19 in total

1.  Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis.

Authors:  Chian Ju Jong; Junichi Azuma; Stephen W Schaffer
Journal:  Exp Clin Cardiol       Date:  2011

2.  Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome.

Authors:  Bjørn Liaset; Qin Hao; Henry Jørgensen; Philip Hallenborg; Zhen-Yu Du; Tao Ma; Hanns-Ulrich Marschall; Mogens Kruhøffer; Ruiqiang Li; Qibin Li; Christian Clement Yde; Gabriel Criales; Hanne C Bertram; Gunnar Mellgren; Erik Snorre Ofjord; Erik-Jan Lock; Marit Espe; Livar Frøyland; Lise Madsen; Karsten Kristiansen
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

Review 3.  The potential protective effects of taurine on coronary heart disease.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Max Costa; Yu Chen
Journal:  Atherosclerosis       Date:  2009-06-11       Impact factor: 5.162

Review 4.  Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.

Authors:  Yukio Yamori; Takashi Taguchi; Atsumi Hamada; Kazuhiro Kunimasa; Hideki Mori; Mari Mori
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

5.  Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets.

Authors:  Yan Zheng; Uta Ceglarek; Tao Huang; Tiange Wang; Yoriko Heianza; Wenjie Ma; George A Bray; Joachim Thiery; Frank M Sacks; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-07-28       Impact factor: 5.958

6.  The mechanism of dietary cholesterol effects on lipids metabolism in rats.

Authors:  Yu-Ming Wang; Bei Zhang; Yong Xue; Zhao-Jie Li; Jing-Feng Wang; Chang-Hu Xue; Teruyoshi Yanagita
Journal:  Lipids Health Dis       Date:  2010-01-14       Impact factor: 3.876

7.  Possible association of high urinary magnesium and taurine to creatinine ratios with metabolic syndrome risk reduction in Australian aboriginals.

Authors:  Atsumi Hamada; Takashi Taguchi; Hideki Mori; Marjorie Thorpe; Yukio Yamori; Mari Mori
Journal:  Cardiol Res Pract       Date:  2011-06-09       Impact factor: 1.866

8.  Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats.

Authors:  Nadia Carla Cheik; Elizeu Antônio Rossi; Ricardo Luís Fernandes Guerra; Neuli Maria Tenório; Cláudia Maria Oller do Nascimento; Fabiana Pavan Viana; Marla Simone Jovenasso Manzoni; Iracilda Zeponni Carlos; Patrícia Leão da Silva; Regina Célia Vendramini; Ana Raimunda Dâmaso
Journal:  Lipids Health Dis       Date:  2008-12-16       Impact factor: 3.876

9.  Polysaccharide from fuzi (FPS) prevents hypercholesterolemia in rats.

Authors:  Xiongqing Huang; Juan Tang; Qin Zhou; Hanping Lu; Yiling Wu; Weikang Wu
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

10.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.